FTC Will Not Challenge Amazon’s $3.49 Billion One Medical Purchase

The Federal Trade Commission won’t challenge Amazon’s $3.49 billion acquisition of One Medical parent 1Life Healthcare, according to people familiar with the decision, a move that will allow the deal to close this week.

The agency plans to issue a letter to the companies warning them that the investigation remains open despite the expiration of the statutory deadline for the antitrust review, the people said, speaking anonymously to discuss a pending deal. The FTC also issued a so-called pre-consummation warning letter when the online retail giant purchased film studio Metro-Goldwyn-Mayer last year.

The One Medical merger marks the second time that the FTC under progressive Chair Lina Khan has declined to block a major deal by Amazon, though the agency’s long-running probe into the retailer continues.

Read the source article at seattletimes.com